CommercialAdministrativeLow impact
00.10.43f, Reimbursement for the Administration of Drugs, Substances, and/or Biologic Agents
Independence Blue Cross·PA · Oncology, Infectious Disease, Hematology +1 more·Claims & Billing
We identified it
Jun 19, 2026
Summary
Independence Blue Cross reissued Policy 00.10.43f on 04/16/2025 with no substantive changes to the reimbursement guidelines for drug, substance, and biologic agent administration. The policy was previously updated on 04/01/2024 to add HCPCS code G0138 (cipaglucosidase alfa-atga infusion) and align with CPT code updates. No new billing codes, coverage changes, or documentation requirements were introduced in this reissue.
Action Required
No immediate action required. This is a reissue with no changes from the previous policy version. Billing teams should verify that current systems already reflect the CPT code updates from 04/01/2024 and include HCPCS code G0138 in billing software. Review the existing policy documentation requirements (start/stop infusion times, medical necessity records) to ensure compliance, but no workflow modifications are needed for this reissue.